Rapamycin, mTOR inhibitor (TBI1104)

Description

Product Details

Formal Name: (7E,15E,17E,19E)-9,10,12,13,14,21,22,23,24,25,26,27,32,33,34aS-Hexadecahydro-9R,27-dihydroxy-3S-[(1R)-2-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethyl]-10R,21S-dimethoxy-6R,8,12R,14S,20,26R-hexamethyl-23S,27R-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine-1,5,11,28,29(4H,6H,31H)-pentone

Alternate Names: Sirolimus; AY-22989; WY-090217; NSC-226080; Rapamune

Molecular Formula: C₅₁H₇₉NO₁₃

Formula Weight: 914.17

CAS Number: 53123-88-9

Purity: >98%

Formulation: Powder

Solubility: Soluble in DMSO (up to 40 mg/ml) or in Ethanol (up to 90 mg/ml).

Storage: -20°C

Stability: ≥ 2 years.

 

Applications

• mTOR inhibitor

 

Related Products

1. TBI1170 Mitomycin C
2. TBI1345 E64, Cysteine protease inhibitor
3. TBI1148 Gefitinib, EGFR Kinase inhibitor
4. TBI2614 ZVAD-FMK, Pan-caspase inhibitor
5. TBI2069 Cytochalasin B

Additional information

SIZE (mg)	10 MG, 50 MG

TBI1104-Rapamycin